msf infographic: keeping vaccines cold a major challenge

1

Keeping Vaccines Cold is a Major Challenge in Developing Countries with Hot Climates In Chad, for example, the temperature can reach 45° C / 113° F but electricity for refrigeration is limited Most vaccines need to be kept between 2-8°C / 35-46°F 113°F 45°C 35-46°F 2-8°C CHAD WE NEED EASIER-TO-USE VACCINES

Upload: medecins-sans-frontieres-south-africa

Post on 06-Mar-2016

213 views

Category:

Documents

0 download

Report

Download

Embed Size (px):

DESCRIPTION

MSF Infographic: Keeping vaccines cold is a major challenge in developing countries with hot climate.

TRANSCRIPT

Page 1: MSF Infographic: Keeping Vaccines Cold a Major Challenge

Keeping Vaccines Cold is a Major Challenge in Developing Countries with Hot Climates

In Chad, for example,the temperature can reach 45° C / 113° Fbut electricity for refrigeration is limited

Most vaccines need to be keptbetween 2-8°C / 35-46°F

113°F45°C

35-46°F2-8°C

CHAD

WE NEED EASIER-TO-USE VACCINES

Msf Impulse 0211

VACCINES - Rutgers Universitybhillman/comparative_virology/Vaccines05.pdf · PREREQUISITES FOR VACCINES: • Vaccines must be safe, efficacious and practical • Vaccines containing

1 in 5vaccines 20 seconds— from vaccine- die each year ......IFPMA-BIO Decade of Vaccines Infographic - April 2013 - #decadeofvaccines. Please share. e Innovative Vaccines Companies

MSF Process model

Msf plandemarketing

Communication de MSF

Presentacion MSF

Vaccines Infographic July2020

MSF Interoperability Testing

eprints.uthm.edu.myeprints.uthm.edu.my/id/eprint/4108/1/shahreen_kasim.pdf · CluFA-I), improving confidence level (msf-CluFA-2) and combination of msf-CluFA-0, msf-CluFA-1 and msf-CluFA-2

Vaccines- Introduction Vaccines- History Immunological Adjuvants Types DNA Vaccines Viral Vectors Mucosal Vaccines Peptide Vaccines Subunit Vaccines Vaccine

COMMERCIAL OFFICE MARKET - downtownny...L M R Etat Mke O Q2 2016 LOWER MANHATTAN YTD LEASING ACTIVITY, 2012 - 2016 Source: CBRE 2.02 MSF 2.46 MSF 3.5 MSF 2.01 MSF 2.03 MSF 0 500,000

1 MSF: Microsoft Solutions Framework. 2 Agenda Introduction MSF Team Model MSF Process Model MSF Project Management Discipline MSF Risk Management

Development in MSF

The RighT ShoT - MSF...The Right Shot: Extending the Reach of Affordable and Adapted Vaccines | 3 v accine p R ice S: en S u R ing vaccine S a R e affo R dable The prices of vaccines

Cancer Vaccines · 1. Antigen vaccines 2. Tumour cell vaccines 3. Anti-Idiotype antibody-based vaccines 4. Dendritic cell vaccines 5. DNA vaccines 6. Viral-vector based vaccines2

MSF SharingTheRoadway

REVISED AGENDA - Home | Michigan Business · 1. MSF Board delegateto each of the MSF Chairperson, MSF Fund Manager, s or MSF State Treasurer Director the authority to make all decisions

COMPONENTES MSF

Finch MSF EA Consultation July 7, 2014 - MSF specific

Workshop on Expanded Access to experimental Ebola vaccines … · The Expanded Access study protocol, which is being discussed with Member States by Médecins Sans Frontières (MSF),

Vaccines and - download.e-bookshelf.de€¦ · 19 Vaccines and Autoimmunity: Meningococcal Vaccines, 185 GiovannaPassaro,AlessandraSoriano,and RaffaeleManna 20 Pneumococcal Vaccines

€¦ · 10/25/2016 Additional Research Thimerosal Contraceptive Vaccines Diploid Cell Vaccines Edible Vaccines GMO Vaccines Live Attenuated Vaccines Plant Vaccines Simian virus 40

Presentazione msf

Chapter 12-Vaccines Traditional vs. rDNA vaccines Subunit vaccines Peptide vaccines Genetic immunization: DNA vaccines Attenuated vaccines Vector vaccines